Bio-Techne (NASDAQ:TECH) just reported results for the third quarter of 2024.
- Bio-Techne reported earnings per share of 48 cents. This was above the analyst estimate for EPS of 45 cents.
- The company reported revenue of $303.43 million.
- This was 3.85% better than the analyst estimate for revenue of $292.19 million.